Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6895426 | 0.70 | — | — | |
| Tempol Hydroxylamine SCHEMBL23902 | 0.67 | GAA (0.56) | GAAL3MBTL1 | |
| SCHEMBL879602 | 0.67 | GAA (0.50) | GAAL3MBTL1 | |
| Tempol Hydroxylamine SCHEMBL987556 | 0.65 | GAA (0.54) | GAAL3MBTL1 | |
| SCHEMBL4802289 | 0.65 | GAA (0.43) | GAAL3MBTL1 | |
| SCHEMBL1814713 | 0.64 | GAA (1.00) | GAAL3MBTL1 | |
| Tempol Hydroxylamine SCHEMBL7099824 | 0.62 | GAA (0.50) | GAAL3MBTL1 | |
| SCHEMBL20961110 | 0.60 | GAA (0.48) | GAAL3MBTL1 | |
| SCHEMBL20960941 | 0.60 | GAA (0.48) | GAAL3MBTL1 | |
| SCHEMBL22122583 | 0.60 | GAA (0.48) | GAAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7442711-B2 | Amelioration of the development of cataracts and other ophthalmic diseases | OTHERA HOLDING, INC. (US) | 2008-10-28 | — | — | US | claimed |